Emily L Hinson (Emily Hinson)
Publication Activity (10 Years)
Years Active: 2017-2024
Publications (10 Years): 7
Publications (10 Years): 7
University of Oxford
Affiliation History
University of Oxford
Sep 30 2016
United Kingdom
Postgraduate Research Assistant :: Department of Psychiatry
University of Oxford
Sep 29 2014
- Sep 29 2016
United Kingdom
Postgraduate Research Assistant :: Nuffield Department of Clinical Neurosciences
Publications
- Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null nullFludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
- Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null nullFludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
- Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null nullFludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
- Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null nullFludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
- James Kolasinski, Emily L Hinson, Amir P Divanbeighi Zand, Assen Rizov, Uzay E Emir, Charlotte Jane Stagg
- Magdalena Nowak, Emily L Hinson, Freek van Ede, Alek Pogosyan, Donato Colella, Andrew J Quinn, Peter Brown, Charlotte Jane Stagg